MENU
PTN
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION

Palatin Technologies (PTN) Ownership - Who owns Palatin Technologies?

Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
4B Cedar Brook Drive
Phone
+1 609 495-2200
Employees
34
Web
https://www.palatin.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
4.42M
P/E Ratio
N/A
Total Cash
3.42M
Projected Growth
N/A
Total Debt
357.74K
Revenue
350K
Risk (Beta)
0.92
Dividend Yield
N/A
Total Cash/Share
0.13
Total Debt/Equity
0.02
Revenue/Share
0.02 USD as % of share price

Fundamentals

PTN
Capitalization
N/A
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
N/A
Revenue
N/A
ROE
N/A
Book Value
N/A
P/B Ratio
N/A
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
N/A
Current Ratio
N/A
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
N/A
Shares Held By Institutions
N/A
Shares Outstanding - Current
N/A
Total Liabilities
N/A
Total Volume MTD
N/A
Value
N/A
Gain YTD
N/A
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of peptide, peptide mimetic and small molecule agonist compounds

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
4B Cedar Brook Drive
Phone
+1 609 495-2200
Employees
34
Web
https://www.palatin.com